Terms: = Leukemia AND DNM2, CMTDI1, 1785, ENSG00000079805, DYNII, DYN2, CMTDIB AND Treatment
4 results:
1. Implication of Dynamin-2 (dnm2) Mutations in Adult T-cell Acute Lymphoblastic leukemia.
Sobh M; Aref S; Al Agdar M; El Zafrany M; El-Sokkary AMA
Asian Pac J Cancer Prev; 2023 Apr; 24(4):1257-1264. PubMed ID: 37116148
[TBL] [Abstract] [Full Text] [Related]
2. Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.
Heinicke T; Krahl R; Kahl C; Cross M; Scholl S; Wolf HH; Hähling D; Hegenbart U; Peter N; Schulze A; Florschütz A; Schmidt V; Reifenrath K; Zojer N; Junghanss C; Sayer HG; Maschmeyer G; Späth C; Hochhaus A; Fischer T; Al-Ali HK; Niederwieser D
Ann Hematol; 2021 Sep; 100(9):2387-2398. PubMed ID: 34232360
[TBL] [Abstract] [Full Text] [Related]
3. Mutational spectrum of adult T-ALL.
Neumann M; Vosberg S; Schlee C; Heesch S; Schwartz S; Gökbuget N; Hoelzer D; Graf A; Krebs S; Bartram I; Blum H; Brüggemann M; Hecht J; Bohlander SK; Greif PA; Baldus CD
Oncotarget; 2015 Feb; 6(5):2754-66. PubMed ID: 25595890
[TBL] [Abstract] [Full Text] [Related]
4. Immunological detection of residual leukaemic disease in the bone marrow of children with acute lymphoblastic leukaemia.
Kumar S; Carr TF; Hann IM; Jones PH; Evans DI
Br Med J; 1978 Mar; 1(6112):544-6. PubMed ID: 272943
[TBL] [Abstract] [Full Text] [Related]
